Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04539951 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pragmatic Trial of Obsessive-compulsive Disorder

Study acronym: Proceed
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2024 to Jun 30, 2027
    • Study completion date: Dec 31, 2024 to Dec 31, 2028
    v7
  2. Eligibility criteria revised
    • Secondary endpoints: 7 to 6
    v6
  3. Primary completion date: Aug 31, 2023 to Jun 30, 2024v5 Show 5 more changesShow less
    • Secondary endpoints: details revised at 2 of 7 entries
    • Study description expanded, about 33 words
    • Site contact updated
    • Collaborators revised (12)
    • Study title shortened, about 9 words
  4. Primary completion date: Aug 31, 2022 to Aug 31, 2023v4 Show 5 more changesShow less
    • Primary endpoint revised
    • Study completion date: Aug 31, 2023 to Dec 31, 2024
    • Eligibility criteria expanded, about 41 words
    • Secondary endpoints: 5 to 7
    • Study description shortened, about 15 words
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2020 to Sep 22, 2020
    • Site details revised
    v3
  6. Start date: Sep 1, 2020 to Oct 1, 2020v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study includes a sequenced clinical trial in order to assess the efficacy of several switching or augment strategies when initial treatment is ineffective，and to provide strong evidence for clinical practice and international guidelines for Obsessive-Compulsive Disorder treatments.
Trial Details
NCT Number NCT04539951
Lead Sponsor Shanghai Mental Health Center
Collaborators: The first specialized hospital of harbin, Guizhou Provincial People's Hospital, First Affiliated Hospital of Jinan University, West China Hospital, Suzhou Psychiatric Hospital, Nanjing Medical University, Wuhan Mental Health Centre, Seventh People's Hospital of Hangzhou, First Affiliated Hospital of Kunming Medical University, General Hospital of Ningxia Medical University, The First Affiliated Hospital of Nanchang University, The Second Affiliated Hospital of Xinxiang Medical University
Conditions
(from sponsor)		 Obsessive-Compulsive Disorder
Related terms Obsessive-Compulsive Disorder
Enrollment 1,600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov